Can we use viral kinetic models to individualize treatment?

Liver Int. 2015 Feb;35(2):297-8. doi: 10.1111/liv.12736.
No abstract available

MeSH terms

  • Hepacivirus / drug effects*
  • Hepatitis C / drug therapy*
  • Humans
  • Models, Biological*
  • Precision Medicine / methods*
  • RNA, Viral / drug effects
  • Silybin
  • Silymarin / pharmacology

Substances

  • RNA, Viral
  • Silymarin
  • Silybin